查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040755

聚合酵素鏈鎖反應(PCR) 市場規模、佔有率和趨勢分析報告：按類型、產品類型、應用、地區和細分市場預測 (2026–2033)

Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type (Conventional PCR, Others), By Product(Consumables & Reagents, Instruments), By Application (Medical & Non-Medical), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

聚合酵素鏈鎖反應(PCR) 市場概述

全球聚合酵素鏈鎖反應(PCR) 市場預計到 2025 年將價值 151.9 億美元，預計到 2033 年將達到 247.8 億美元。

預計從 2026 年到 2033 年，該市場將以 6.36% 的複合年成長率成長。這一市場成長是由臨床、研究和法醫學領域對快速、準確的分子診斷的需求不斷成長所推動的。

PCR技術能夠擴增DNA和RNA的小片段，因此可以精確檢測病原體、基因突變和生物標記。

感染疾病、遺傳性疾病和癌症的日益流行正在加速醫院、診斷檢查室和研究機構對基於聚合酶鍊式聚合酵素鏈鎖反應（PCR）的檢測方法的採用。此外，分子診斷和個人化醫療的擴展也強化了PCR技術在現代醫療保健系統中的作用。然而，一些關鍵因素，例如PCR在實驗室和法醫學實驗室的廣泛應用，以及對先進診斷方法日益成長的需求，預計將推動PCR檢測的需求成長。此外，新技術的湧現和合約研究組織（CRO）的增加也將在預測期內推動PCR檢測的需求成長。

預計在預測期內，慢性病、感染疾病和遺傳性疾病的日益普遍將推動市場需求。根據美國疾病管制與預防中心（CDC）統計，癌症、糖尿病等慢性病以及氣喘等慢性腎臟病和呼吸道疾病占美國每年死亡人數的70%。此外，先天性心臟疾病患兒數量的增加也促使醫療專業人員尋求分子診斷工具以達到精準診斷。根據CDC統計，先天性心臟疾病是美國最常見的出生缺陷，每年約有1%的新生兒患有此病。因此，該疾病盛行率的上升將在預測期內推動對新型分子診斷測試的需求。

隨著人們對囊腫纖維化、血友病和地中海貧血等遺傳疾病的認知不斷提高，產前基因檢測的需求日益成長，預計將推動該行業的發展。在懷孕初期，qPCR 和 dPCR 技術可用於分析母體血液或羊水中存在的胎兒 DNA，從而在出生前檢測出遺傳缺陷。這使得在懷孕早期對可能存在遺傳異常或基因缺陷的胎兒進行適當的干涉成為可能。

即時PCR(qPCR)、數位螢光定量PCR (dPCR) 和多重螢光定量PCR等技術的進步提高了診斷檢測的敏感度、特異性和處理能力。新冠肺炎疫情顯著加強了全球PCR檢測基礎建設，促使企業加強對自動化系統和高通量平台的投資。賽默飛世爾科技、Bio-Rad Laboratories、凱傑、羅氏和安捷倫科技等領先企業持續研發先進的PCR儀器、試劑和耗材，以支援臨床診斷、藥物研發和生物技術應用。人們對疾病早期檢測的日益關注、基因組學研究的不斷擴展以及政府對分子生物學研究投入的增加，預計將進一步推動市場成長。

目錄

第1章聚合酵素鏈鎖反應（PCR）市場：調查方法與範圍

第2章聚合酵素鏈鎖反應（PCR）市場：執行摘要

  • 市場概覽
  • 類型概述
  • 產品概述
  • 應用概述
  • 競爭格局概述

第3章聚合酵素鏈鎖反應(PCR) 市場：變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場譜系展望
  • 市場動態
  • 市場動態分析
  • 市場限制因素分析
  • 波特五力分析
  • PESTEL 分析
  • 管道分析

第4章聚合酵素鏈鎖反應(PCR) 市場：按類型分類的估算與趨勢分析

  • 全球聚合酵素鏈鎖反應(PCR) 市場：按類型分類的概覽
  • 全球聚合酵素鏈鎖反應(PCR) 市場：基於類型的波動分析
  • 全球聚合酵素鏈鎖反應(PCR) 市場：依品牌、按銷售收入分類
  • 常規PCR
  • 其他

第5章聚合酵素鏈鎖反應（PCR）市場：產品特定估算與趨勢分析

  • 全球聚合酵素鏈鎖反應(PCR) 市場：產品概覽
  • 全球聚合酵素鏈鎖反應(PCR) 市場：基於產品的波動分析
  • 全球聚合酵素鏈鎖反應(PCR) 市場：依產品及銷售收入分類
  • 耗材和試劑
  • 裝置
  • 軟體服務

第6章聚合酵素鏈鎖反應(PCR) 市場：按應用分類的估算與趨勢分析

  • 全球聚合酵素鏈鎖反應(PCR) 市場：基於應用的儀錶板
  • 全球聚合酵素鏈鎖反應(PCR) 市場：基於應用的波動分析
  • 全球聚合酵素鏈鎖反應(PCR) 市場：按應用和銷售收入分類
  • 醫學領域
    • 臨床階段
    • 研究
    • 法醫學及其他
  • 非醫療
    • 食物
    • 其他

第7章聚合酵素鏈鎖反應（PCR）市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • Thermo Fisher Scientific Inc.
    • Danaher
    • Abbott
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Stilla
    • Standard BioTools
    • Microsynth AG
Product Code: GVR-4-68039-188-0

Polymerase Chain Reaction Market Summary

The global polymerase chain reaction market size was estimated at USD 15.19 billion in 2025 and is projected to reach USD 24.78 billion by 2033, growing at a CAGR of 6.36% from 2026 to 2033. The market growth is driven by the increasing demand for rapid and accurate molecular diagnostics across clinical, research, and forensic applications.

PCR technology enables the amplification of small segments of DNA or RNA, allowing for precise detection of pathogens, genetic mutations, and biomarkers.

The growing prevalence of infectious diseases, genetic disorders, and cancer has accelerated the adoption of PCR-based testing in hospitals, diagnostic laboratories, and research institutes. In addition, the expansion of molecular diagnostics and personalized medicine has strengthened the role of PCR technologies in modern healthcare systems.However, some of the key factors, such as the rising application of polymerase chain reaction (PCR) in research and forensic laboratories and increasing demand for advanced diagnostics, are anticipated to increase the demand for polymerase chain reaction tests. In addition, the launch of novel technologies and the increasing number of contract research organizations are likely to drive demand for PCR tests forward during the forecast period.

The increase in the prevalence of chronic and infectious diseases and genetic disorders is expected to boost the demand during the forecast period. According to the CDC, chronic diseases such as cancer and diabetes, and chronic kidney and respiratory diseases such as asthma, are responsible for 7 in 10 deaths in the U.S. each year. Furthermore, the number of patients suffering from congenital heart disease is increasing, requiring medical professionals to look for molecular diagnostic tools for accurate diagnoses. According to the CDC, congenital heart defects are the most common birth defects in the U.S., affecting approximately 1% of births every year. Thus, the increasing prevalence of diseases is increasing the demand for novel molecular diagnostic tests during the forecast period.

The rising demand for prenatal genetic testing procedures owing to growing awareness regarding genetic disorders, such as cystic fibrosis, hemophilia, and thalassemia, is expected to propel the industry growth. In the early stages of pregnancy, fetal DNA present in the mother's blood or the amniotic fluid can be analyzed to detect genetic defects before birth using qPCR and dPCR techniques. Possible genetic aberrations and fetuses with defective genes can then be treated during early pregnancy.

Technological advancements such as real-time PCR (qPCR), digital PCR (dPCR), and multiplex PCR have improved sensitivity, specificity, and throughput in diagnostic testing. The COVID-19 pandemic significantly boosted global PCR testing infrastructure, leading to increased investments in automated systems and high-throughput platforms. Major companies such as Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche, and Agilent Technologies continue to develop advanced PCR instruments, reagents, and consumables to support clinical diagnostics, pharmaceutical research, and biotechnology applications. The growing focus on early disease detection, expanding genomic research, and increasing government funding for molecular biology research are expected to further drive market growth.

Global Polymerase Chain Reaction Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global polymerase chain reaction market report based on the type, product, application, and region:

  • Type Method Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
  • Conventional PCR
  • Others
  • Product Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
  • Consumables & Reagents
  • Instruments
  • Software & Services
  • Application Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
  • Medical
    • Clinical
    • Pathology Testing
    • Oncology Testing
    • Blood Screening
    • Others
    • Research
    • Forensics and Others
  • Non-medical
    • Food
    • Others
  • Regional Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

Table of Contents

Chapter 1. Polymerase Chain Reaction Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Product Segment
      • 1.1.1.3. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Polymerase Chain Reaction Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type Snapshot
  • 2.3. Product Snapshot
  • 2.4. Application Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Polymerase Chain Reaction Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
  • 3.5. Market Restraint Analysis
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Polymerase Chain Reaction Market: Type Estimates & Trend Analysis

  • 4.1. Global Polymerase Chain Reaction Market: Type Dashboard
  • 4.2. Global Polymerase Chain Reaction Market: Type Movement Analysis
  • 4.3. Global Polymerase Chain Reaction Market by brand, Revenue
  • 4.4. Conventional PCR
    • 4.4.1. Conventional PCR market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Polymerase Chain Reaction Market: Product Estimates & Trend Analysis

  • 5.1. Global Polymerase Chain Reaction Market: Product Dashboard
  • 5.2. Global Polymerase Chain Reaction Market: Product Movement Analysis
  • 5.3. Global Polymerase Chain Reaction Market by Product, Revenue
  • 5.4. Consumables & Reagents
    • 5.4.1. Consumables & Reagents market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Software & Services
    • 5.6.1. Software & Services market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Polymerase Chain Reaction Market: Application Estimates & Trend Analysis

  • 6.1. Global Polymerase Chain Reaction Market: Application Dashboard
  • 6.2. Global Polymerase Chain Reaction Market: Application Movement Analysis
  • 6.3. Global Polymerase Chain Reaction Market by Application, Revenue
  • 6.4. Medical
    • 6.4.1. Medical market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.2. Clinical
      • 6.4.2.1. Clinical market estimates and forecasts, 2021 to 2033 (USD Million)
      • 6.4.2.2. Pathology Testing
        • 6.4.2.2.1. Pathology Testing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 6.4.2.3. Oncology Testing
        • 6.4.2.3.1. Oncology Testing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 6.4.2.4. Blood Screening
        • 6.4.2.4.1. Blood Screening market estimates and forecasts, 2021 to 2033 (USD Million)
      • 6.4.2.5. Others
        • 6.4.2.5.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.3. Research
      • 6.4.3.1. Research market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.4.4. Forensics and Others
      • 6.4.4.1. Forensics and Others market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Non-Medical
    • 6.5.1. Non-Medical market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Food
      • 6.5.2.1. Food market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Polymerase Chain Reaction Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. Thermo Fisher Scientific Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Danaher
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Abbott
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Bio-Rad Laboratories, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Agilent Technologies, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. F. Hoffmann-La Roche Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Stilla
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Standard BioTools
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Microsynth AG
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Polymerase Chain Reaction Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 North America Polymerase Chain Reaction Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 U.S Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 U.S Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 Canada Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Mexico Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Europe Polymerase Chain Reaction Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 23 Europe Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 France Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 France Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 France Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 29 Germany Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 UK Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 UK Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 UK Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 Spain Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Spain Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Spain Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Italy Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Italy Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 Italy Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Asia Pacific Polymerase Chain Reaction Market, By Country, 2021 - 2033 (USD Million)
  • Table 40 Asia Pacific Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 43 Japan Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Japan Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 45 Japan Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 46 China Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 47 China Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 China Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 India Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 India Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 India Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 South Korea Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 South Korea Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 54 South Korea Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 Australia Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Australia Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Australia Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 Latin America Polymerase Chain Reaction Market, By Country, 2021 - 2033 (USD Million)
  • Table 59 Latin America Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Latin America Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 61 Latin America Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 62 Brazil Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 63 Brazil Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Brazil Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 65 Argentina Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 66 Argentina Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Argentina Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 68 MEA Polymerase Chain Reaction Market, By Country, 2021 - 2033 (USD Million)
  • Table 69 MEA Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 70 MEA Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 71 MEA Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 72 South Africa Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 South Africa Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 74 South Africa Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 75 Saudi Arabia Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 76 Saudi Arabia Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 77 Saudi Arabia Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 UAE Polymerase Chain Reaction Market, By Type, 2021 - 2033 (USD Million)
  • Table 79 UAE Polymerase Chain Reaction Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 UAE Polymerase Chain Reaction Market, By Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Polymerase chain reaction market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Polymerase chain reaction market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Polymerase chain reaction market: Type movement analysis
  • Fig. 14 Polymerase chain reaction market: Type outlook and key takeaways
  • Fig. 15 Conventional PCR market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Others estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Polymerase chain reaction market: Test type movement analysis
  • Fig. 18 Polymerase chain reaction market: Test type outlook and key takeaways
  • Fig. 19 Consumables & Reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Instruments estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Software & Services estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Polymerase chain reaction market: Application movement analysis
  • Fig. 23 Polymerase chain reaction market: Application outlook and key takeaways
  • Fig. 24 Medical market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Clinical estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Pathology Testing estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Oncology Testing estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Blood Screening estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Others estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Research estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Forensics and Others estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Non-medical estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Food estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Others estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Global polymerase chain reaction market: Regional movement analysis
  • Fig. 36 Global polymerase chain reaction market: Regional outlook and key takeaways
  • Fig. 37 Global polymerase chain reaction market share and leading players
  • Fig. 38 North America, by country
  • Fig. 39 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 U.S key country dynamics
  • Fig. 41 U.S market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Canada key country dynamics
  • Fig. 43 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico key country dynamics
  • Fig. 45 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea key country dynamics
  • Fig. 65 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil key country dynamics
  • Fig. 70 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Argentina key country dynamics
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa key country dynamics
  • Fig. 75 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Saudi Arabia key country dynamics
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 UAE key country dynamics
  • Fig. 79 UAE market estimates and forecasts, 2021 - 2033 (USD Million)